Development of an Interferon-γ ELISPOT Assay to Assess Varicella-Zoster Virus-Specific Cell-Mediated Immunity in Children
Open Access
- 1 January 2026
- journal article
- Published by XMLink in Infection & Chemotherapy
- Vol. 58
Abstract
Han MS, et al. Infect Chemother. 2026 ;58:e42. https://doi.org/10.3947/ic.2026.0039Keywords
Funding Information
- Korean Society of Pediatric Infectious Diseases
This publication has 20 references indexed in Scilit:
- Long-term immunogenicity of a live attenuated herpes zoster vaccine in patients with systemic lupus erythematosusVaccine, 2025
- Identification and Characterization of Antigen-Specific T-Cells in Viral Infections2024
- Immune response to varicella-zoster virus before and after renal transplantationAntiviral Research, 2020
- Increased risk of herpes zoster in children with cancerMedicine, 2016
- Varicella zoster virus infectionNature Reviews Disease Primers, 2015
- CMV‐specific T‐cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot studyClinical Transplantation, 2010
- Measurement of Varicella‐Zoster Virus (VZV)–Specific Cell‐Mediated Immunity: Comparison between VZV Skin Test and Interferon‐γ Enzyme‐Linked Immunospot AssayThe Journal of Infectious Diseases, 2008
- Quantification and characterization of specific T-cells by antigen-specific cytokine production using ELISPOT assay or intracellular cytokine stainingMethods, 2003
- Quantitation of antigen-reactive T cells in peripheral blood by IFNγ-ELISPOT assay and chromium-release assay: a four-centre comparative trialJournal of Immunological Methods, 2000
- Frequencies of Memory T Cells Specific for Varicella‐Zoster Virus, Herpes Simplex Virus, and Cytomegalovirus by Intracellular Detection of Cytokine ExpressionThe Journal of Infectious Diseases, 2000